BVS vs PH · rev $573.3M vs P/E 28, rev $19.85B
Bioventus Inc (BVS) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
BVS currently screens at market cap $495.1M. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the BVS and PH stock pages for the full models.
Not investment advice.